SK

Sanjay Kumar Sthapak

Active Director Director DIN 11439374
DIN 11439374 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Kumar Sthapak

Data last updated:

Sanjay Kumar Sthapak is a Director at Zedcure Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11439374
Primary Designation Director
Industry Pharma
First Appointment 19 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20252025Active

Board colleagues of Sanjay Kumar Sthapak

NameDINCompanyDesignation
Samarth Pachori11439373Zedcure Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zedcure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjay Kumar Sthapak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Sthapak

Sanjay Kumar Sthapak currently holds 1 directorship: Zedcure Pharmaceuticals Private Limited (Director, since 19 Dec 2025).

Sanjay Kumar Sthapak was first appointed on 19 Dec 2025 as Director at Zedcure Pharmaceuticals Private Limited.

The current boards of Sanjay Kumar Sthapak's companies include Samarth Pachori (Zedcure Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available